XML 84 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pure Sunfarms Acquisitions
12 Months Ended
Dec. 31, 2021
Business Combinations [Abstract]  
Acquisitions

6

PURE SUNFARMS ACQUISITION

On November 2, 2020, Village Farms consummated a definitive purchase and sale agreement with Emerald Health Therapeutics Inc. (“Emerald”), acquiring 36,958,500 Common Shares in the capital of Pure Sunfarms owned by Emerald, and increasing Village Farms’ ownership of Pure Sunfarms to 100%. The shares were acquired for a total purchase price of C$79.9 million (US$60.0 million), satisfied through an initial C$60.0 million (US$45.0 million) cash payment and a C$19.9 million (US$15.0 million) secured promissory note payable to Emerald, which was repaid in full on February 8, 2021.

The acquisition was deemed a business combination and the purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. The Company used information available to make fair value determinations and engaged independent valuation specialists to assist in the fair value determination of acquired intangible assets. The estimated fair value of licenses was determined using a multi-period excess earnings method. This earnings-based method considers the net present value of the licenses’ cash flows discounted at an asset specific discount rate. The net present value attributable to the licenses deducts the contributory asset charges used in connection with the licenses. The estimated fair value of the brand was determined using the relief-from-royalty method. This method assumes that the brand has value to the extent that their owner is relieved of the obligation to pay royalties for the benefits received from them. This method requires the Company to estimate the future revenues for the related brand, the appropriate royalty rate, and an asset specific discount rate. This measure of fair value requires significant judgment about the value a market participant would be willing to pay to achieve the benefits associated with the brand. Acquired property, plant and equipment and software were valued using the replacement cost method, which requires the Company to estimate the costs to construct an asset of equivalent utility at prices available at the time of the valuation analysis, with adjustments in value for physical deterioration and functional and economic obsolescence. Upon the acquisition of Pure Sunfarms, the Company identified goodwill of C$30,618 (US$24,108). This goodwill was calculated as the difference between the fair value of the consideration issued for the acquisition of Pure Sunfarms and the fair value of all assets and liabilities acquired. The goodwill is attributable to the acquired workforce and potential for growth through the conversion of the Delta 1 greenhouse facility and future accretive acquisitions. The Company is required to record a deferred tax liability for the difference between the assigned values and the tax bases of assets acquired and liabilities assumed. None of the goodwill is deductible for tax purposes. As a result of the acquisition, the Company also recognized a gain of $23.6 million due to the revaluation of its previously held investment in Pure Sunfarms to its fair value at the acquisition date. The accounting for the business combination was considered complete for the year ended December 31, 2020.  

 

 

The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date:

Consideration paid

 

Shares

 

 

Share Price

 

 

Amount

 

Cash

 

 

 

 

 

 

 

 

 

$

45,259

 

Promissory note

 

 

 

 

 

 

 

 

 

 

15,011

 

Shareholder loan

 

 

 

 

 

 

 

 

 

 

4,529

 

Promissory note owed to PSF from Emerald

 

 

 

 

 

 

 

 

 

 

439

 

Due to related party

 

 

 

 

 

 

 

 

 

 

61

 

Fair value of previously held investment shares held by Village Farms

 

 

52,569,197

 

 

$

1.767

 

 

 

92,881

 

Total fair value of consideration

 

 

 

 

 

 

 

 

 

$

158,180

 

 

 

 

November 2, 2020

 

ASSETS

 

 

 

 

Cash and cash equivalents

 

$

10,860

 

Trade receivables, net

 

 

10,553

 

Inventories

 

 

32,393

 

Prepaid expenses and deposits

 

 

3,572

 

Property, plant and equipment

 

 

122,831

 

Goodwill

 

 

23,095

 

Intangibles

 

 

16,670

 

Total assets

 

 

219,974

 

LIABILITIES

 

 

 

 

Trade payables

 

$

3,849

 

Accrued liabilities

 

 

13,062

 

Income taxes payable

 

 

2,173

 

Current maturities of long-term debt

 

 

2,306

 

Deferred revenue

 

 

77

 

Long-term debt

 

 

23,903

 

Deferred tax liabilities

 

 

16,424

 

Total liabilities

 

 

61,794

 

Net assets acquired

 

 

158,180

 

 

The change in goodwill between November 2, 2020 and December 31, 2021 is due to the effect of foreign currency translation.

 

Prior to its acquisition on November 2, 2020, the Company accounted for its investment in Pure Sunfarms, using the equity method. The Company determined that Pure Sunfarms was a variable interest entity (“VIE”), however the Company did not consolidate Pure Sunfarms because the Company was not the primary beneficiary. Although the Company was able to exercise significant influence over the operating and financial policies of Pure Sunfarms through its then 58.7% majority interest, the Company shared joint control of the board of directors and therefore was not the primary beneficiary. For the three and nine months ended September 30, 2020, the Company’s equity earnings from Pure Sunfarms were $1,443 and $5,437, respectively.

On March 2, 2020, pursuant to the Settlement Agreement, Emerald transferred to the Company 2.5% of additional equity in Pure Sunfarms. The Company determined the fair value of the equity received from Emerald to be C$6.5 million (US$4.7 million). The Company recorded this amount as a gain and included it as a gain on settlement agreement on the Consolidated Statement of Income (Loss) and Comprehensive Income (Loss) for the year ended December 31, 2020.

 

For the period January 1, 2020 to November 1, 2020, the Company’s share of the joint venture consisted of the following:

 

Balance, January 1, 2020

 

$

41,334

 

Investments in joint venture

 

 

16,393

 

Share of net income for the year

 

 

4,980

 

Balance, November 1, 2020

 

$

62,707